Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 1246 AL 1260

Editorial: Insights into Parkinson's disease and aging related movement disorders

Petersen RB, Walter B.

Front Aging Neurosci. 2023 May 17;15:1193197. doi: 10.3389/fnagi.2023.1193197. eCollection 2023.

Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers

Sugier PE, Lucotte EA, Domenighetti C, Law MH, Iles MM, Brown K, Amos C, McKay JD, Hung RJ, Karimi M, Bacq-Daian D, Boland-Augé A, Olaso R, Deleuze JF, Lesueur F, Ostroumova E, Kesminiene A, de Vathaire F, Guénel P; EPITHYR consortium; Sreelatha AAK, Schulte C, Grover S, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Nakayama A, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BPC, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Guedes LC, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen N, Ran C, Belin AC, Puschmann A, Rödström EY, Clarke CE, Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Kruger R, Gasser T, Sharma M; Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (Courage-PD) consortium; Truong T, Elbaz A.

Mov Disord. 2023 Apr;38(4):604-615. doi: 10.1002/mds.29337. Epub 2023 Feb 14.

Two-Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individuals

Siepmann T, Arndt M, Sedghi A, Szatmári S Jr, Horváth T, Takáts A, Bereczki D, Moskopp ML, Buchmann S, Skowronek C, Zago W, Woranush W, Lapusca R, Weidemann ML, Gibbons CH, Freeman R, Reichmann H, Puetz V, Barlinn K, Pintér A, Illigens BM.

Eur J Neurol. 2023 May;30(5):1281-1292. doi: 10.1111/ene.15733. Epub 2023 Feb 24.

Neurophysiology of Brain Networks Underlies Symptoms of Parkinson's Disease: A Basis for Diagnosis and Management

Acosta-Mejia MT, Villalobos N.

Diagnostics (Basel). 2023 Jul 18;13(14):2394. doi: 10.3390/diagnostics13142394.

Significant potential of melatonin therapy in Parkinson's disease - a meta-analysis of randomized controlled trials

Iftikhar S, Sameer HM, Zainab.

Front Neurol. 2023 Oct 10;14:1265789. doi: 10.3389/fneur.2023.1265789. eCollection 2023.

Impaired night-time mobility in patients with Parkinson's disease: a systematic review

Li S, Lin Q, Bao Y, Feng Y, Li D, Zhang C.

Front Aging Neurosci. 2023 Nov 22;15:1264143. doi: 10.3389/fnagi.2023.1264143. eCollection 2023.

[Observation on the efficacy of different targets low-frequency repetitive transcranial magnetic stimulation for the treatment of tremor-dominant subtypes of Parkinson's disease]

Qi C, Zhao JH, Wei YR, Gan J, Wan Y, Wu N, Song L, Zhang Y, Liu ZG.

Zhonghua Yi Xue Za Zhi. 2023 Oct 24;103(39):3112-3118. doi: 10.3760/cma.j.cn112137-20230629-01102.

Transcranial direct current stimulation suggests not improving postural control during adapted tandem position in people with Parkinson's disease: A pilot study

Legutke BR, Gobbi LTB, Orcioli-Silva D, Santos PCRD, Moraca GAG, Vitório R, Beretta VS.

Behav Brain Res. 2023 Aug 24;452:114581. doi: 10.1016/j.bbr.2023.114581. Epub 2023 Jul 13.

Effect of Gushen shetuo decoction in improving motor and non-motor symptoms and the expression of PERK, ATF4 and CHOP in patients with Parkinson's disease

Li P, Yang N, Guo W, Ning H, Cheng W, Wang H.

Cell Mol Biol (Noisy-le-grand). 2023 Dec 10;69(13):174-179. doi: 10.14715/cmb/2023.69.13.27.

High (130 Hz)- and mid (60 Hz)-frequency deep brain stimulation in the subthalamic nucleus differentially modulate response inhibition: A preliminary combined EEG and eye tracking study

Waldthaler J, Sperlich A, König A, Stüssel C, Bremmer F, Timmermann L, Pedrosa D.

Neuroimage Clin. 2023;37:103314. doi: 10.1016/j.nicl.2023.103314. Epub 2023 Jan 5.

Quality of life implications for elevated trait impulsivity in people with Parkinson's disease

Jeyadevan A, Bakeberg M, Byrnes M, Kenna J, McGregor S, Ghosh S, Horne MK, Stell R, Evans T, Mastaglia FL, Anderton R.

Qual Life Res. 2023 Apr;32(4):1143-1150. doi: 10.1007/s11136-022-03321-w. Epub 2023 Jan 13.

Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms

Domen CH, Sillau S, Liu Y, Adkins M, Rajkovic S, Bainbridge J, Sempio C, Klawitter J, Leehey MA.

Mov Disord. 2023 Jul;38(7):1341-1346. doi: 10.1002/mds.29447. Epub 2023 May 22.

Lisbon Intensive Falls Trampoline Training (LIFTT) Program for people with Parkinson's for balance, gait, and falls: study protocol for a randomized controlled trial

Domingos J, Dean J, Fernandes JB, Ramos C, Grunho M, Proença L, Vaz JR, Godinho C.

Trials. 2023 Feb 8;24(1):101. doi: 10.1186/s13063-023-07131-4.

Intermittent theta-burst stimulation combined with physical therapy as an optimal rehabilitation in Parkinson's disease: study protocol for a randomised, double-blind, controlled trial

Jin ZH, Wang YX, Meng DT, Qin Y, Duan YN, Fang JP, Wang RD, Liu YJ, Liu C, Wang P, Yan HJ, Zhen Y, An X, Chen KK, Yu X, Lyu D, Yan XY, Fang BY.

Trials. 2023 Jun 16;24(1):410. doi: 10.1186/s13063-023-07425-7.

Timely referral for device-aided therapy in Parkinson's disease. Development of a screening tool

Moes HR, Ten Kate JM, Portman AT, van Harten B, van Kesteren ME, Mondria T, Lunter G, Buskens E, van Laar T.

Parkinsonism Relat Disord. 2023 Apr;109:105359. doi: 10.1016/j.parkreldis.2023.105359. Epub 2023 Mar 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias